Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratko Djukanovic

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopyMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
BMC Systems Biology|May 31, 2018
A computational framework for complex disease stratification from multiple large-scale datasetsBertrand De Meulder, Diane Lefaudeux, Aruna T Bansal, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omicsDiane Lefaudeux, Bertrand De Meulder, Matthew J Loza, et al.
ERJ Open Research|October 27, 2022
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS studyAnne-Noelle Frix, Liam G Heaney, Barbro Dahlén, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma controlXue Zeng, Jing Qing, Chi-Ming Li, et al.
The Lancet. Respiratory Medicine|May 29, 2026
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort studyJennifer Logan, Kirsty Martin, Lynsey Gillespie, et al.
The European Respiratory Journal|September 28, 2019
Management of severe asthma: a European Respiratory Society/American Thoracic Society guidelineFernando Holguin, Juan Carlos Cardet, Kian Fan Chung, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2020
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopyMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
The Journal of Allergy and Clinical Immunology|July 31, 2017
Pathway discovery using transcriptomic profiles in adult-onset severe asthmaPieter-Paul Hekking, Matt J Loza, Stelios Pavlidis, et al.
The European Respiratory Journal|September 29, 2017
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthmaPieter-Paul Hekking, Matthew J Loza, Stelios Pavlidis, et al.
BMC Systems Biology|May 31, 2018
A computational framework for complex disease stratification from multiple large-scale datasetsBertrand De Meulder, Diane Lefaudeux, Aruna T Bansal, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2016
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omicsDiane Lefaudeux, Bertrand De Meulder, Matthew J Loza, et al.
ERJ Open Research|October 27, 2022
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS studyAnne-Noelle Frix, Liam G Heaney, Barbro Dahlén, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma controlXue Zeng, Jing Qing, Chi-Ming Li, et al.
The Lancet. Respiratory Medicine|May 29, 2026
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort studyJennifer Logan, Kirsty Martin, Lynsey Gillespie, et al.
The European Respiratory Journal|September 28, 2019
Management of severe asthma: a European Respiratory Society/American Thoracic Society guidelineFernando Holguin, Juan Carlos Cardet, Kian Fan Chung, et al.
Pageof 13